RYLPF
Price
$27.72
Change
+$0.37 (+1.35%)
Updated
Sep 4 closing price
Capitalization
25.69B
SARTF
Price
$187.87
Change
-$2.13 (-1.12%)
Updated
Aug 22 closing price
Capitalization
14.38B
Interact to see
Advertisement

RYLPF vs SARTF

Header iconRYLPF vs SARTF Comparison
Open Charts RYLPF vs SARTFBanner chart's image
Koninklijke Philips N.V
Price$27.72
Change+$0.37 (+1.35%)
Volume$160
Capitalization25.69B
Sartorius AG
Price$187.87
Change-$2.13 (-1.12%)
Volume$1
Capitalization14.38B
RYLPF vs SARTF Comparison Chart in %
Loading...
RYLPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SARTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RYLPF vs. SARTF commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYLPF is a Buy and SARTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (RYLPF: $27.72 vs. SARTF: $187.87)
Brand notoriety: RYLPF and SARTF are both not notable
RYLPF represents the Medical/Nursing Services, while SARTF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RYLPF: 13% vs. SARTF: 8%
Market capitalization -- RYLPF: $25.69B vs. SARTF: $14.38B
RYLPF [@Medical/Nursing Services] is valued at $25.69B. SARTF’s [@Pharmaceuticals: Other] market capitalization is $14.38B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.15B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RYLPF’s FA Score shows that 1 FA rating(s) are green whileSARTF’s FA Score has 0 green FA rating(s).

  • RYLPF’s FA Score: 1 green, 4 red.
  • SARTF’s FA Score: 0 green, 5 red.
According to our system of comparison, RYLPF is a better buy in the long-term than SARTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RYLPF’s TA Score shows that 3 TA indicator(s) are bullish while SARTF’s TA Score has 3 bullish TA indicator(s).

  • RYLPF’s TA Score: 3 bullish, 3 bearish.
  • SARTF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, RYLPF is a better buy in the short-term than SARTF.

Price Growth

RYLPF (@Medical/Nursing Services) experienced а +0.77% price change this week, while SARTF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.15%. For the same industry, the average monthly price growth was +4.26%, and the average quarterly price growth was +24.89%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.57%. For the same industry, the average monthly price growth was +6.79%, and the average quarterly price growth was +18.37%.

Industries' Descriptions

@Medical/Nursing Services (-0.15% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.57% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RYLPF($25.7B) has a higher market cap than SARTF($14.4B). RYLPF has higher P/E ratio than SARTF: RYLPF (148.94) vs SARTF (107.66). RYLPF YTD gains are higher at: 9.790 vs. SARTF (2.103). RYLPF has higher annual earnings (EBITDA): 2.41B vs. SARTF (844M). RYLPF has more cash in the bank: 1.82B vs. SARTF (872M). SARTF has less debt than RYLPF: SARTF (4.66B) vs RYLPF (8.43B). RYLPF has higher revenues than SARTF: RYLPF (17.9B) vs SARTF (3.47B).
RYLPFSARTFRYLPF / SARTF
Capitalization25.7B14.4B178%
EBITDA2.41B844M286%
Gain YTD9.7902.103465%
P/E Ratio148.94107.66138%
Revenue17.9B3.47B516%
Total Cash1.82B872M209%
Total Debt8.43B4.66B181%
FUNDAMENTALS RATINGS
RYLPF vs SARTF: Fundamental Ratings
RYLPF
SARTF
OUTLOOK RATING
1..100
2887
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9187
PRICE GROWTH RATING
1..100
5160
P/E GROWTH RATING
1..100
1288
SEASONALITY SCORE
1..100
3785

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RYLPF's Valuation (58) in the null industry is in the same range as SARTF (77). This means that RYLPF’s stock grew similarly to SARTF’s over the last 12 months.

RYLPF's Profit vs Risk Rating (100) in the null industry is in the same range as SARTF (100). This means that RYLPF’s stock grew similarly to SARTF’s over the last 12 months.

SARTF's SMR Rating (87) in the null industry is in the same range as RYLPF (91). This means that SARTF’s stock grew similarly to RYLPF’s over the last 12 months.

RYLPF's Price Growth Rating (51) in the null industry is in the same range as SARTF (60). This means that RYLPF’s stock grew similarly to SARTF’s over the last 12 months.

RYLPF's P/E Growth Rating (12) in the null industry is significantly better than the same rating for SARTF (88). This means that RYLPF’s stock grew significantly faster than SARTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RYLPFSARTF
RSI
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
64%
Momentum
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
49%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
55%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 3 days ago
52%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
RYLPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SARTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDTX64.931.50
+2.36%
Cidara Therapeutics
HQY97.702.16
+2.26%
HealthEquity
DYCQU11.10N/A
N/A
DT Cloud Acquisition Corp
RXST8.47-0.42
-4.72%
RxSight
QNTM14.29-1.41
-8.98%
Quantum Biopharma Ltd

RYLPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RYLPF has been loosely correlated with MTD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RYLPF jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RYLPF
1D Price
Change %
RYLPF100%
+1.36%
MTD - RYLPF
38%
Loosely correlated
+1.51%
CDNA - RYLPF
28%
Poorly correlated
+2.91%
MBGNF - RYLPF
24%
Poorly correlated
N/A
SRTS - RYLPF
23%
Poorly correlated
-2.15%
WRBY - RYLPF
21%
Poorly correlated
+0.36%
More

SARTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SARTF has been loosely correlated with SDMHF. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SARTF jumps, then SDMHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SARTF
1D Price
Change %
SARTF100%
N/A
SDMHF - SARTF
39%
Loosely correlated
N/A
SOAGY - SARTF
27%
Poorly correlated
-3.52%
EXAS - SARTF
21%
Poorly correlated
+4.34%
RSMDF - SARTF
16%
Poorly correlated
N/A
RYLPF - SARTF
9%
Poorly correlated
+1.36%
More